Logo

American Heart Association

  2
  0


Final ID: Mo4181

Impact of Postoperative Atrial Fibrillation on Long-term Clinical Outcomes in Patients after Coronary Artery Bypass Grafting

Abstract Body (Do not enter title and authors here): Background: The impact of postoperative atrial fibrillation (POAF) after coronary artery bypass grafting (CABG) on long-term clinical outcomes has not been adequately evaluated yet.
Methods: Among consecutive 14927 patients who underwent their first coronary revascularization in the CREDO-Kyoto PCI/CABG Registry Cohort-3 (2011-2013), the study population consisted of 1483 patients who underwent CABG after excluding those with prior AF. POAF was defined as newly documented AF during hospitalization for CABG. The primary outcome measure was all-cause death after discharge. The median clinical follow-up was 5.7 (interquartile range, 4.4-6.6) years.
Results: POAF was observed in 337 patients (23%). Multivariable logistic regression analysis indicated that age >=75 years (odds ratio [OR], 1.61; 95% confidence interval [CI], 1.24-2.10; P<0.001) and cardiopulmonary bypass (CPB) use (OR, 1.40; 95%CI, 1.09-1.79; P=0.01) were independent predictors of POAF. Of the 1400 patients discharged alive among the study population, the POAF group included more older patients, patients with prior stroke, and patients prescribed beta-blockers and oral anticoagulants than the non-POAF group. The cumulative 5-year incidence of all-cause death was 15.9% in the POAF group and 13.0% in the non-POAF group (Log-rank P=0.38). After adjusting for confounders, the adjusted risk for all-cause death was almost neutral (adjusted HR, 0.96; 95%CI, 0.70-1.31; P=0.81). The cumulative 5-year incidence of stroke was significantly higher in the POAF group than in the non-POAF group (8.0% versus 4.2%; Log-rank P=0.02), and the adjusted risk of stroke in the POAF group relative to the non-POAF group tended to be higher (adjusted HR: 1.58, 95%CI, 0.99-2.53; P=0.057). However, the cumulative 5-year incidence of major bleeding was significantly higher in the POAF group than in the non-POAF group (14.6% versus 10.7%; Log-rank P=0.01). Even after adjusting for confounders, the excess risk of major bleeding in the POAF group was significant (adjusted HR, 1.42; 95%CI, 1.01-2.00; P=0.041).
Conclusions: Advanced age and CPB use were associated with POAF occurrence. POAF was not associated with long-term mortality after discharge. However, it tended to be associated with a higher risk for stroke and was associated with a significantly higher risk for major bleeding. Further study would be needed to clarify the appropriate management of POAF after CABG.
  • Kuroda, Yuki  ( Graduate School of Medicine, Kyoto University , Kyoto , Japan )
  • Kanemitsu, Hideo  ( Kitano Hospital , Osaka , Japan )
  • Tsuneyoshi, Hiroshi  ( Shizuoka General Hospital , Shizuoka , Japan )
  • Kanemitsu, Naoki  ( Japanese Red Cross Wakayama Medical Center , Wakayama , Japan )
  • Iwakura, Atsushi  ( Osaka Red Cross Hospital , Osaka , Japan )
  • Tamura, Nobushige  ( Hyogo Prefectural Amagasaki General Medical Center , Amagasaki , Japan )
  • Furukawa, Yutaka  ( Kobe City Medical Center General Hospital , Kobe , Japan )
  • Kadota, Kazushige  ( Kurashiki Central Hospital , Kurashiki , Japan )
  • Ando, Kenji  ( Kokura Memorial Hospital , Kitakyushu , Japan )
  • Ohno, Nobuhisa  ( Kokura Memorial Hospital , Kitakyushu , Japan )
  • Komiya, Tatsuhiko  ( Kurashiki Central Hospital , Kurashiki , Japan )
  • Shiomi, Hiroki  ( Kyoto University Graduate School of Medicine , Kyoto , Japan )
  • Kimura, Takeshi  ( Hirakata Kohsai Hospital , Hirakata , Japan )
  • Minatoya, Kenji  ( Graduate School of Medicine, Kyoto University , Kyoto , Japan )
  • Morimoto, Takeshi  ( Hyogo Medical University , Nishinomiya , Japan )
  • Hirao, Shingo  ( Kurashiki Central Hospital , Kurashiki , Japan )
  • Tsubota, Hideki  ( Mitsubishi Kyoto Hospital , Kyoto , Japan )
  • Matsuo, Takehiko  ( Graduate School of Medicine, Kyoto University , Kyoto , Japan )
  • Uehara, Kyokun  ( Tenri Hospital , Tenri , Japan )
  • Esaki, Jiro  ( Kobe City Medical Center General Hospital , Kobe , Japan )
  • Shimamoto, Takeshi  ( Hamamatsu Rosai Hospital , Hamamatsu , Japan )
  • Author Disclosures:
    Yuki Kuroda: DO NOT have relevant financial relationships | Hideo Kanemitsu: No Answer | Hiroshi Tsuneyoshi: No Answer | Naoki Kanemitsu: No Answer | Atsushi Iwakura: No Answer | Nobushige Tamura: DO NOT have relevant financial relationships | Yutaka Furukawa: DO NOT have relevant financial relationships | Kazushige Kadota: No Answer | Kenji Ando: DO have relevant financial relationships ; Consultant:Boston Scinetific:Past (completed) ; Consultant:BIOTRONIK JAPAN:Past (completed) ; Speaker:Abbott Medical Japan:Active (exists now) ; Consultant:Japan lifeline:Past (completed) ; Speaker:Medtronic Japan:Past (completed) | Nobuhisa Ohno: No Answer | Tatsuhiko Komiya: DO NOT have relevant financial relationships | Hiroki Shiomi: DO NOT have relevant financial relationships | Takeshi Kimura: DO NOT have relevant financial relationships | Kenji Minatoya: DO NOT have relevant financial relationships | Takeshi Morimoto: DO NOT have relevant financial relationships | Shingo Hirao: DO NOT have relevant financial relationships | Hideki Tsubota: No Answer | Takehiko Matsuo: No Answer | Kyokun Uehara: DO NOT have relevant financial relationships | Jiro Esaki: DO NOT have relevant financial relationships | Takeshi Shimamoto: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Innovations and Outcomes in Coronary Artery Bypass Grafting: Techniques and Interventions

Monday, 11/18/2024 , 10:30AM - 11:30AM

Abstract Poster Session

More abstracts on this topic:
A machine learning approach to classifying ischemic stroke etiology using variables available in the Get-with-the-Guidelines Stroke Registry

Lee Ho-joon, Schwamm Lee, Turner Ashby, De Havenon Adam, Kamel Hooman, Brandt Cynthia, Zhao Hongyu, Krumholz Harlan, Sharma Richa

Efficacy of a Glucagon-Like Peptide-1 Agonist in Patients undergoing Coronary Artery Bypass Grafting or Aortic Valve Replacement – a randomized clinical trial

Kjaergaard Jesper, Boesgaard Soeren, Kober Lars, Nilsson Jens Christian, Hassager Christian, Moeller Christian Holdflod, Wiberg Sebastian, Mikkelsen Astrid, Møller-sørensen Peter Hasse, Ravn Hanne Berg, Ravn Jesper, Olsen Peter Skov, Høfsten Dan

More abstracts from these authors:
Rivaroxaban for 18 Months versus 6 Months in Cancer Patients with Low-risk Pulmonary Embolism: ONCO PE Trial

Yamashita Yugo, Morimoto Takeshi, Muraoka Nao, Shioyama Wataru, Chatani Ryuki, Shibata Tatsuhiro, Nishimoto Yuji, Ono Koh, Kimura Takeshi

Transplantation of vascularized cardiac microtissue derived from human iPS cells improves impaired electrical conduction capacity in a porcine myocardial injury model

Kuroda Yuki, Iida Jun, Murata Kozue, Kobiki Jumpei, Minatoya Kenji, Masumoto Hidetoshi

You have to be authorized to contact abstract author. Please, Login
Not Available